HomeOpen Access NewsAlzheimer's Disease

Alzheimer's Disease

Dementia in Europe to soar 64% by 2050, Alzheimer’s report warns

Alzheimer Europe forecasts dementia in Europe to rise 64% by 2050, highlighting urgent health and policy needs.

Graph theory in the study of Alzheimer’s disease progression

María J. Peláez1, Prashant Dogra1, Zhihui Wang1, Vittorio Cristini1 1Mathematics in Medicine Program, Houston Methodist Research Institute, Houston, TX 77030, USA.

Understanding the difference between Dementia and Alzheimer’s

Ella Hendrix, Writer, takes it back to basics and explains the difference between Dementia and Alzheimer's disease

A brief overview of advances in neurodegenerative diseases

Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group, provides an overview of Neurodegenerative Diseases.

Vitamin B12 and brain health of older people

Here, Professor Timothy Kwok discusses the impact of vitamin B12 on the brain health of older people.

Data linkage and sharing for healthy longevity: A global challenge

Data linkage and sharing for healthy longevity together present a global challenge, in the view of Prof Makoto Suematsu, Japan Agency for Medical Research and Development and Rihana Diabo at the World Economic Forum.

Hearing loss and the link with dementia

If we address hearing loss, can we really decrease our risk of developing dementia? Mark Atkinson, Chief Executive Action of Hearing Loss investigates.

Intramembrane proteases in neurodegenerative diseases

Prof Dr Regina Fluhrer, from the University of Augsburg, explains how intramembrane proteases have been implicated in the emergence of neurodegenerative diseases.

New health-data programme to detect diseases early

Diseases could be detected even before people experience symptoms, thanks to a pioneering new health-data programme as part of the government’s modern Industrial Strategy.

Virtual reality can spot problems in early Alzheimer’s disease

The University of Cambridge found that virtual reality (VR) can identify early Alzheimer’s disease better than ‘gold standard’ cognitive tests currently in use.

Up to 2 million will live with dementia by 2050

According to the Alzheimer Society 850,000 people in the UK have dementia but with 1 in 6 people over the age of 80 living with dementia, this is predicted to rise to over 2 million by 2050 as the population ages.

Supporting vital Alzheimer’s disease research in the U.S and beyond

The work of the National Institute on Aging (NIA) is placed into focus here, with examples of how they are supporting vital Alzheimer’s disease research in the U.S and further afield.

Defining dementia and Alzheimer’s in the 21st century

Paul Edwards, Director of Clinical Services at Dementia UK, explores what dementia actually means in the 21st century, including the all-important differences between dementia and Alzheimer’s.

Bold action by Congress delivers victory to millions living with Alzheimer’s

Rachel Conant, Senior Director, Federal Affairs, Alzheimer’s Association explains how bold action by the U.S. Congress delivers victory to the millions of people living with Alzheimer's.

Scientists reveal largest ever map of human Alzheimer’s brain

On the 4th February 2019, a scientific breakthrough for the future of Alzheimer's brain reserach has been published - read on to explore the developments.

Turning up the volume of the patient voice in dementia research

Dr James Pickett, Head of Research at Alzheimer’s Society presents the case for turning up the volume of the patient voice when it comes.

Treatment and diagnosis of neurodegenerative disorders

Andrea Varrone studies the importance of molecular imaging to provide personalised medicine and improve care for patients with neurodegenerative disorders

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders